Report Id: SNS/HC/2620 | July 2022 | Region: Global | 130 Pages
Report Scope & Overview:
The Bladder Cancer Detection Kit Market Size was valued at USD 212.44 million in 2022, and is expected to reach USD 507.40 million by 2030, and grow at a CAGR of 11.5% over the forecast period 2023-2030.
Malignant cells form in the tissues of the bladder in the common type of cancer known as bladder cancer. The lining of the bladder, called urothelium, is where it frequently starts. Both the kidneys and the ureters contain these cells. Urothelial carcinoma can therefore develop in the ureters and kidneys. Bladder cancer detection kits are offered by a number of firms all over the world, and there are still a number of items in the R&D stage.
The incidence of bladder cancer is rising.
Ageing population expanding
Increasing spending on research and development to produce bladder cancer detection kits
Worries about the sale of the products in the developing world
The accessibility of cutting-edge diagnostic tools
Ageing and geriatric populations are more likely than younger ones to have bladder cancer.
Lack of awareness
IMPACT OF COVID-19
People all across the world have been impacted by the pandemic, which has forced the closure of operational facilities everywhere. During the lockdown period, the healthcare business is experiencing unusual situations. The closure of the manufacturing facilities had an impact on the creation of medical items. The medical product supply chain was also impacted, which reduced the manufactured goods' warehouse inventory.
Therefore, it is advised against urologists delaying an inquiry. The present need for bladder cancer testing kits has increased as a result of this. The market for bladder cancer testing kits will expand as a result of the pandemic, and it is predicted that it will grow quickly after the lockdown.
In the discipline of urology, Fluorescence In Situ Hybridization (FISH) is employed to give a non-invasive diagnostic alternative to cystoscopy. This unique urine screening technique uses fluorescent direct-labeled DNA probes to identify genetic changes in the urothelial cells detected in the urine. One of the FISH-based products produced by Abbott Laboratories is called UroVysion (US).
ELISA: Enzyme-Linked Immunosorbent Assay
Minichromosome maintenance complex component 5 (MCM5) protein is detected with this method because it serves as a biomarker for cancer. People who exhibit symptoms of cancer, such as blood in the urine, can also be diagnosed with bladder cancer using this method.
By End User
Hospitals and Clinics: The bladder cancer detection kit market is being driven by improvements in hospital infrastructure around the world. By building facilities for cancer diagnosis and treatment, the investors are leveraging the bladder cancer market.
Diagnostic Center: Because bladder cancer may be diagnosed right away and there are rarely substantial wait times, demand is rising. These procedures are affordable at the diagnostic facilities.
Some of the major key players are as follows: Alfa Scientific Designs, Diagnosis S.A., Abingdon Health, Exact Sciences, Abbott Laboratories, NanoEnTek Inc., Xiamen Biotime Biotechnology, Ameritek, Inc., Nanjing Liming Bio-products Co., Ltd, Hubei Jinjian Biology, Xiamen Boson Biotech Co., Ltd.
Fluorescence In Situ Hybridization (FISH)
Enzyme-Linked Immunosorbent Assay (ELISA)
By End User
A growing number of people are developing bladder cancer in North America, which accounts for the market share of bladder cancer detection kits.
The existence of significant competitors in the market, the availability of cutting-edge diagnostic tools, and well-established research institutions involved in product development all contribute to the growth of the bladder cancer detection kit market. The major players are launching new goods, collaborating and partnering, and expanding their operating facilities throughout the region in order to develop their businesses.
Ageing populations' increased risk of bladder cancer is driving the Asia-Pacific bladder cancer detection kit market.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
|Market Size in 2022||US$ 212.44 Million|
|Market Size by 2030||US$ 408.38 Million|
|CAGR||CAGR of 11.5% From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Technology (Fluorescence In Situ Hybridization (FISH), Enzyme-Linked Immunosorbent Assay (ELISA))
• By End User (Hospitals& Clinics, Diagnostic Centers)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Alfa Scientific Designs, Diagnosis S.A., Abingdon Health, Exact Sciences, Abbott Laboratories, NanoEnTek Inc., Xiamen Biotime Biotechnology, Ameritek, Inc., Nanjing Liming Bio-products Co., Ltd, Hubei Jinjian Biology, Xiamen Boson Biotech Co., Ltd.|
|Key Drivers||• The incidence of bladder cancer is rising.
• Ageing population expanding
|RESTRAINTS||• Worries about the sale of the products in the developing world|
Frequently Asked Questions (FAQ) :
Ans Bladder Cancer Detection Kit Market Size was valued at USD 190.53 million in 2021, and expected to reach USD 408.21 million by 2028, and grow at a CAGR of 11.5% over the forecast period 2022-2028.
Ans. The incidence of bladder cancer is rising, and Ageing population expanding are the key drivers of the Bladder Cancer Detection Kit market
Ans. A growing number of people are developing bladder cancer in North America, which accounts for the market share of bladder cancer detection kits.
Ans. Alfa Scientific Designs, Diagnosis S.A., Abingdon Health, Exact Sciences, Abbott Laboratories, NanoEnTek Inc. are the key players of Bladder Cancer Detection Kit market
Ans. The present need for bladder cancer testing kits has increased as a result of this. The market for bladder cancer testing kits will expand as a result of the pandemic, and it is predicted that it will grow quickly after the lockdown.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.2 Impact on major economies
184.108.40.206 United Kingdom
220.127.116.11 South Korea
18.104.22.168 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Bladder Cancer Detection Kit Market Segmentation, By Technology
8.1 Fluorescence in Situ Hybridization (FISH)
8.2 Enzyme-Linked Immunosorbent Assay (ELISA)
9. Bladder Cancer Detection Kit Market Segmentation, By End User
9.1 Hospitals& Clinics
9.2 Diagnostic Centers
10. Regional Analysis
10.2 North America
10.3.6 The Netherlands
10.3.7 Rest of Europe
10.4.2 South Korea
10.4.6 Rest of Asia-Pacific
10.5 The Middle East & Africa
10.5.3 South Africa
10.6 Latin America
10.6.3 Rest of Latin America
11.1 Alfa Scientific Designs
11.1.2 Products/ Services Offered
11.1.3 SWOT Analysis
11.1.4 The SNS view
11.2 Diagnosis S.A.
11.3 Abingdon Health
11.4 Exact Sciences
11.5 Abbott Laboratories
11.6 NanoEnTek Inc.
11.7 Xiamen Biotime Biotechnology
11.8 Ameritek, Inc.
11.9 Nanjing Liming Bio-products Co., Ltd
11.10 Hubei Jinjian Biology
12.1 Competitive Benchmark
12.2 Market Share analysis
12.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of a good and accurate research report and selecting the best methodology to complete the research is the toughest part. Since the research reports, we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach a stage wherein we can provide our clients best and most accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brainstorming sessions to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research as the name suggests is a research process wherein, we collect data through readily available information. In this process, we use various paid and unpaid databases to which our team has access and gather data through the same. This includes examining listed companies’ annual reports, Journals, SEC filling, etc. Apart from this, our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various universities as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content-specific facts that can be sued to solve specific problems. Since the collected data is fresh and first-hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply sides of the industry to make sure we land an accurate judgment and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses, and observation of on-field participants. The below-mentioned chart should give a better understanding of part 1 of the primary interview.
Part 2: In this part of the primary research the data collected via secondary research and part 1 of the primary research is validated with the interviews with individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence center, our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real-time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but is not limited to getting rid of the many typos, duplication of numbers, or missing any important information. The people involved in this process include technical content writers, research heads, and graphics people. Once this process is completed the title gets uploaded on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.